Besides, although PEDF has shown strong therapeutic potential in the ophthalmology field, only one Phase I clinical study has shown that an adenovirus carrying PEDF exerted a therapeutic effect in patients with advanced neovascular age-related macular degeneration. Here, SERPINF1 is linked to age-related macular degeneration.